Fifth Third Bancorp lessened its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,198,227 shares of the company’s stock after selling 15,275 shares during the quarter. Procter & Gamble makes up approximately 1.1% of Fifth Third Bancorp’s portfolio, making the stock its 17th biggest holding. Fifth Third Bancorp owned 0.09% of Procter & Gamble worth $337,758,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. WP Advisors LLC lifted its position in shares of Procter & Gamble by 4.9% during the 2nd quarter. WP Advisors LLC now owns 1,405 shares of the company’s stock valued at $224,000 after buying an additional 66 shares during the last quarter. Emprise Bank raised its stake in Procter & Gamble by 2.5% in the 3rd quarter. Emprise Bank now owns 2,766 shares of the company’s stock valued at $425,000 after acquiring an additional 68 shares during the period. Affiance Financial LLC lifted its holdings in Procter & Gamble by 2.5% during the third quarter. Affiance Financial LLC now owns 2,803 shares of the company’s stock valued at $431,000 after purchasing an additional 69 shares during the last quarter. Vermillion & White Wealth Management Group LLC boosted its position in Procter & Gamble by 12.9% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 621 shares of the company’s stock worth $99,000 after purchasing an additional 71 shares during the period. Finally, Dominguez Wealth Management Solutions Inc. increased its stake in shares of Procter & Gamble by 0.3% in the third quarter. Dominguez Wealth Management Solutions Inc. now owns 20,464 shares of the company’s stock worth $3,144,000 after purchasing an additional 71 shares in the last quarter. 65.77% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
PG has been the subject of several analyst reports. JPMorgan Chase & Co. raised shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $157.00 to $165.00 in a report on Friday, January 23rd. TD Cowen lowered Procter & Gamble from a “buy” rating to a “hold” rating and raised their price target for the stock from $150.00 to $156.00 in a report on Tuesday, January 27th. Raymond James Financial decreased their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, December 29th. Finally, Barclays set a $155.00 target price on Procter & Gamble in a report on Friday, January 16th. Thirteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $167.67.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $160.11 on Monday. The stock’s 50-day simple moving average is $147.14 and its two-hundred day simple moving average is $150.40. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $179.99. The firm has a market capitalization of $372.09 billion, a P/E ratio of 23.72, a P/E/G ratio of 5.32 and a beta of 0.38. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. The company had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.Procter & Gamble’s revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, January 23rd. This represents a $4.23 annualized dividend and a dividend yield of 2.6%. Procter & Gamble’s dividend payout ratio (DPR) is 62.67%.
Insider Activity at Procter & Gamble
In other news, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the transaction, the chief executive officer directly owned 34,994 shares in the company, valued at approximately $5,680,576.02. This represents a 50.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Marc S. Pritchard sold 95,903 shares of the business’s stock in a transaction that occurred on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the completion of the sale, the insider owned 182,607 shares of the company’s stock, valued at $27,601,048.05. The trade was a 34.43% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 326,091 shares of company stock worth $51,795,360 in the last three months. 0.20% of the stock is owned by insiders.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Modest fundamental support from recent results — P&G posted a slight EPS beat in its most recent quarter and set FY‑2026 EPS guidance in the 6.83–7.09 range, which largely aligns with Street expectations and supports the stock’s valuation relative to peers. MarketBeat PG Summary
- Neutral Sentiment: Brand/marketing update — P&G’s Native brand released a feature‑length “microsoap” series as a marketing push; positive for brand engagement but unlikely to move near‑term earnings materially. PR Newswire: Native microsoap launch
- Neutral Sentiment: Analyst commentary on valuation and headwinds — Recent pieces note a YTD rally under new CEO but warn premium valuation, tariff pressures and margin squeeze could limit upside; useful context for positioning but not immediate catalysts. Zacks: Time to Buy or Wait?
- Neutral Sentiment: Macro/competitive note — Coverage noting P&G’s YTD rally but that it lags some rivals and faces tariff challenges; informative for relative performance analysis. 247WallSt: Rallies Under New CEO
- Negative Sentiment: Large insider selling — Multiple senior insiders disclosed sizable sales over Feb 11–12: CEO Gary Coombe sold ~36,093 shares (~$5.86M) and Chairman Jon Moeller reported sales totaling ~173,268 shares (two filings) worth tens of millions; another insider sold ~12,827 shares. Heavy insider selling can be interpreted as a near‑term negative signal for sentiment/liquidity. SEC filings: Coombe Form 4 Moeller Form 4 (both) Purushothaman Form 4
- Negative Sentiment: Regulatory risk in Italy — Italy’s competition authority opened an investigation into allegedly misleading advertising for a P&G epilator product; potential reputational, remediation or fines risk depending on outcome. Reuters: Italy probe
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Trump & Musk’s Secret Bet on Silver — Exposed
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
